David Torchiana, MD

President and CEO, Partners HealthCare

President and CEO, Partners HealthCare

Dr. Torchiana graduated from Yale College in 1976, was a Churchill scholar at Cambridge University in 1977, and graduated from Harvard Medical School in 1981. He completed residencies in general surgery and cardiothoracic surgery at MGH before joining the department of surgery in 1989. Dr. Torchiana became chief of cardiac surgery at MGH in 1998 and chairman and CEO of the Massachusetts General Physicians Organization in 2003.  

In March of 2015, he was appointed as president and CEO of Partners HealthCare, an integrated not-for-profit academic health system founded by Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) in 1994. Partners also includes McLean Hospital, Massachusetts Eye and Ear, the Spaulding Rehabilitation Network of post-acute institutional and home care services, eight community hospitals, Neighborhood Health Plan (a not-for-profit health insurance company), and a community physician network. MGH and BWH are the largest hospital recipients of National Institutes of Health funding in the nation, and in aggregate, Partners total research budget is $1.4 billion. In the field of education, Partners academic hospitals are teaching affiliates of Harvard Medical School, have over 200 residency and fellowship programs and include the MGH Institute of Health Professions, a graduate school with 1,200 students in nursing and other allied-health professions. Partners has an annual operating budget of 13 billion dollars and employs approximately 74,000 faculty and staff. 

Dr. Torchiana’s principal career interest has been to make health care better and more cost effective. 




Professor Garthwaite is the Herman R. Smith Research Professor in Hospital and Health Service, an Associate Professor of Strategy, and the Director of the Program on Healthcare at Kellogg (HCAK). He is an applied microeconomist whose research examines the effects of government policies and social phenomena with a focus on health and biopharmaceutical sectors. His recent work has focused on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of non-profit hospitals to financial shocks. In prior work, he has examined the impact of government cash assistance programs on health and the effect of changes in expected mortality from the emergence of crack-cocaine markets on educational attainment.

Professor Garthwaite also studies questions of pricing and innovation in the biopharmaceutical sector. In this area he has examined the effect of expanded patent protection on pricing in the Indian pharmaceutical market, the innovation response of United States pharmaceutical firms to increases in demand, and the relationship between health insurance expansions and high drug prices.  

Garthwaite received a B.A. and a Masters in Public Policy from the University of Michigan and his PhD in Economics from the University of Maryland.  Prior to receiving his PhD, he served in a variety of public policy positions including the Director of Research for the Employment Policies Institute. He has testified before the United States House of Representatives and several state legislatures on matters related to the minimum wage and health care reforms.